ACH Alberta Children’s Hospital
aGvHD Acute graft versus host disease
ALL Acute lymphoblastic leukemia
ATG Anti-thymocyte globulin
AUC Area under the curve
BM Bone marrow
Bu Busulfan
CAR-T Chimeric antigen receptor T-cell
cGvHD Chronic graft versus host disease
CHC Chemotherapy-based conditioning
CI Confidence interval
CIR Cumulative incidences of relapse
CMV Cytomegalovirus
Cy Cyclophosphamide
EBV Epstein Barr Virus
EFS Event free survival
Flu Fludarabine
FORUM For Omitting Radiation Under Majority age
GvHD Graft versus host disease
HLA Human leukocyte antigen
HSCT Hematopoietic stem cell transplantation
IgG Immunoglobulin G
IQR Interquartile range
IV Intravenous
MRD Minimal Residual Disease
NRM Non-relapse mortality
OS Overall survival
PBSC Peripheral blood stem cell
SOS Sinusoidal obstructive syndrome
TBI Total body irradiation
TDM Targeted drug monitoring
Treo Treosulfan